A detailed history of Bank Of America Corp transactions in Alector, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 362,900 shares of ALEC stock, worth $696,768. This represents 0.0% of its overall portfolio holdings.

Number of Shares
362,900
Previous 359,385 0.98%
Holding current value
$696,768
Previous $1.63 Million 3.86%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.34 - $6.58 $15,255 - $23,128
3,515 Added 0.98%
362,900 $1.69 Million
Q2 2024

Aug 14, 2024

BUY
$4.19 - $6.23 $24,025 - $35,722
5,734 Added 1.62%
359,385 $1.63 Million
Q1 2024

May 15, 2024

SELL
$5.69 - $8.08 $493,118 - $700,245
-86,664 Reduced 19.68%
353,651 $2.13 Million
Q4 2023

Feb 14, 2024

BUY
$3.77 - $8.39 $321,015 - $714,408
85,150 Added 23.97%
440,315 $3.51 Million
Q2 2023

Aug 14, 2023

SELL
$5.86 - $7.93 $683,791 - $925,335
-116,688 Reduced 24.73%
355,165 $2.13 Million
Q1 2023

May 12, 2023

BUY
$5.85 - $9.84 $278,068 - $467,724
47,533 Added 11.2%
471,853 $2.92 Million
Q4 2022

Feb 10, 2023

BUY
$6.88 - $9.55 $385,142 - $534,609
55,980 Added 15.2%
424,320 $3.92 Million
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $1.13 Million - $1.83 Million
138,363 Added 60.16%
368,340 $3.48 Million
Q2 2022

Aug 12, 2022

SELL
$7.65 - $14.24 $785,463 - $1.46 Million
-102,675 Reduced 30.87%
229,977 $2.34 Million
Q1 2022

May 16, 2022

SELL
$13.02 - $20.78 $1.02 Million - $1.63 Million
-78,356 Reduced 19.06%
332,652 $4.74 Million
Q4 2021

Feb 08, 2022

BUY
$19.35 - $25.54 $2.75 Million - $3.62 Million
141,861 Added 52.71%
411,008 $8.49 Million
Q3 2021

Nov 15, 2021

BUY
$21.65 - $39.49 $3.06 Million - $5.58 Million
141,372 Added 110.64%
269,147 $6.14 Million
Q2 2021

Sep 13, 2021

BUY
$15.5 - $22.48 $1.98 Million - $2.87 Million
127,775 New
127,775 $2.66 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $159M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.